- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02777060
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
16. mai 2016 oppdatert av: Bijan Najafi, University of Arizona
Explore the benefit of the game-based virtual reality system in improving lower extremity kinematics and balance in patients suffering from disease/disorders including Diabetes, Cancer, Multiple Sclerosis, Arthritis, Parkinson's disease, Cognitive Disorders, Brain Injury, Stroke or Frailty.
A four to six weeks of training with 2 training session/week will be provided.
Studieoversikt
Status
Ukjent
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Individuals suffering from certain disorders/diseases including diabetes, arthritis, cancer, osteoarthritis, stroke, Parkinson's disease, cognitive impairment or brain Injury are more likely to experience a fall or a fall-related injury than healthy individuals during to impaired postural stability or diminished joint perception.
Under certain circumstance they may also experience pain, depression, anxiety, and a decreased quality of life.
The investigators' research has been designed to provide exercise training using non-invasive body-worn sensors (similar to those used in an iPhone®) to provide real-time visual information about joint motion in a virtual environment.
These sensors will be worn using a vest, t-shirt or elastic band.
The investigators will, 1) assess changes in participant's perception of lower extremity position while they perform these exercises; 2) motivate and guide simple exercise performance in the clinic/home, using an interactive game-like scheme; and 3) assess changes in participant's postural stability and gait as a result of provided exercise training.
The information gathered will provide new understanding about more helpful rehabilitation strategies that improve postural stability in patient population.
Studietype
Intervensjonell
Registrering (Forventet)
200
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Arizona
-
Tucson, Arizona, Forente stater, 85724
- Rekruttering
- University of Arizona
-
Ta kontakt med:
- Bijan S Najafi, PhD
- Telefonnummer: 713-798-0477
- E-post: najafi.bijan@gmail.com
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
Diagnosis of:
- diabetes
- cancer
- multiple sclerosis
- arthritis
- Parkinson's disease
- cognitive disorders
- brain injury
- frailty
- stroke
Exclusion Criteria:
- conditions not related to specific disorders affecting balance and gait
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Exergame
inertial sensor based system (wearable sensors, LEGSys, Biosensics LLC) will be used for balance training with computerized feedback.
The balance training program is focused on lower extremities including ankle joint exercise and virtual obstacle crossing tasks.
|
Subjects will perform progressive and computerized foot and ankle exercises which include weight shifting, ankle reaching task while standing, and virtual obstacle crossing task (i.e.
balancing on single leg) using wearable sensors technology (Exergaming) equipment).
Subjects will perform these exercises for 4-6 weeks, twice per week.
The duration of exercise per session is anticipated to be 30-45 minutes.
Andre navn:
|
|
Aktiv komparator: Home based balance training
The control group will ask to perform a home based program includes similar exercise components as proposed in the experimental group, however without computerized feedback.
Exercises include postural balance tasks, such as backward and forward weight shifting, as well as dynamic balance exercises, such as marching in place (comparable to virtual obstacle crossing in experimental group).
|
Subjects in the control group will ask to perform a standard home based balance program for 4-6 weeks.
The home based program includes similar exercise components as proposed in the experimental group, however without computerized feedback and Exergaming equipment.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Balance
Tidsramme: 4-6 weeks
|
Balance will be quantified by measuring area of sway of center of mass (with unit of cm2) during quite standing according to Romberg's protocol and using validated instrument (BalanSens, Biosensics, MA, USA)
|
4-6 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in gait Speed
Tidsramme: 4-6 weeks
|
Gait Speed (with unit of m/sec) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking
|
4-6 weeks
|
|
Change in Stride length
Tidsramme: 4-6 weeks
|
Stride Length (with unit of meter) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking
|
4-6 weeks
|
|
Change in Stride time
Tidsramme: 4-6 weeks
|
Stride time (with unit of second) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking
|
4-6 weeks
|
|
Change in number of walking steps per day
Tidsramme: 4-6 weeks
|
Average of walking steps (no unit) per day will be measured during 48 hours of daily physical activity monitoring using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
|
Change in average of walking bout
Tidsramme: 4-6 weeks
|
Daily average of walking bout (continuous walking without stop, with unit of steps) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
|
Change in average of standing bout
Tidsramme: 4-6 weeks
|
Daily average of standing bout (continuous standing without changing in posture with unit of seconds) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
|
Change in average of longest walking bout
Tidsramme: 4-6 weeks
|
Daily average of longest walking bout (longest continuous walking without stop per day, with unit of steps) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. september 2014
Primær fullføring (Forventet)
1. desember 2016
Studiet fullført (Forventet)
1. august 2017
Datoer for studieregistrering
Først innsendt
8. juni 2015
Først innsendt som oppfylte QC-kriteriene
16. mai 2016
Først lagt ut (Anslag)
19. mai 2016
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
19. mai 2016
Siste oppdatering sendt inn som oppfylte QC-kriteriene
16. mai 2016
Sist bekreftet
1. mai 2016
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Psykiske lidelser
- Hjernesykdommer
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Sykdommer i immunsystemet
- Demyeliniserende autoimmune sykdommer, CNS
- Autoimmune sykdommer i nervesystemet
- Demyeliniserende sykdommer
- Autoimmune sykdommer
- Sår og skader
- Nevrokognitive lidelser
- Parkinsonlidelser
- Basal ganglia sykdommer
- Bevegelsesforstyrrelser
- Synukleinopatier
- Nevrodegenerative sykdommer
- Kraniocerebralt traume
- Traumer, nervesystemet
- Multippel sklerose
- Parkinsons sykdom
- Hjerneskader
- Kognisjonsforstyrrelser
Andre studie-ID-numre
- 1409482826
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .